Le Lézard

RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as a ...
KATC

Baroque on the Bayou returns May 22–24

Baroque on the Bayou returns May 22–24, 2026, for its second annual celebration of Baroque music in the heart of South ...

I Drove the 2026 Toyota C-HR EV: An Honest Review of Toyota’s Compact Electric SUV

There's an old idea—romanticized by road movies, Hollywood mythology, and more than a few cheesy car ads—that if you put someone behind the wheel on the right stretch of pavement, the truth about the ...